These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28041821)

  • 1. NAT positivity in seronegative voluntary blood donors from western India.
    Mishra KK; Trivedi A; Sosa S; Patel K; Ghosh K
    Transfus Apher Sci; 2017 Apr; 56(2):175-178. PubMed ID: 28041821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation and follow up of initial "NAT yields": Prospective study from a tertiary healthcare center in India.
    Pandey P; Tiwari AK; Dara RC; Rawat GS; Negi A; Raina V
    Transfus Apher Sci; 2016 Apr; 54(2):242-7. PubMed ID: 26321477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India.
    Hans R; Marwaha N; Sharma S; Sachdev S; Sharma RR
    Indian J Med Res; 2019 May; 149(5):633-640. PubMed ID: 31417031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The results of nucleic acid testing in remunerated and non-remunerated blood donors in Lithuania.
    Kalibatas V; Kalibatienė L
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s58-62. PubMed ID: 24120587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
    Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
    Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
    Galel SA; Simon TL; Williamson PC; AuBuchon JP; Waxman DA; Erickson Y; Bertuzis R; Duncan JR; Malhotra K; Vaks J; Huynh N; Pate LL
    Transfusion; 2018 Mar; 58(3):649-659. PubMed ID: 29250788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
    Stramer SL; Notari EP; Krysztof DE; Dodd RY
    Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing blood transfusion safety using molecular detection in the country of Georgia.
    Alkhazashvili M; Bloch EM; Shadaker S; Kuchuloria T; Getia V; Turdziladze A; Armstrong PA; Gamkrelidze A
    Transfus Clin Biol; 2023 Aug; 30(3):307-313. PubMed ID: 36907246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid amplification testing in Indian blood banks: A review with perspectives.
    Ghosh K; Mishra K
    Indian J Pathol Microbiol; 2017; 60(3):313-318. PubMed ID: 28937364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase.
    Ren FR; Wang JX; Huang Y; Yao FZ; Lv YL; Li JL; Wen GX; Wen XQ; Liu J; Dong XD; Ma HL; Zhou ZM; Bi XH; Tu L; King M; Nelson K; Ness P; Shan H
    Transfusion; 2011 Dec; 51(12):2588-95. PubMed ID: 21682731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan.
    Niazi SK; Bhatti FA; Salamat N; Ghani E; Tayyab M
    Transfusion; 2015 Jul; 55(7):1803-11. PubMed ID: 25648663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.